Latest News about bmy
Recent news which mentions bmy
Bristol Myers' Opdivo Under Priority FDA Review In Neoadjuvant Lung Cancer Setting
February 28, 2022
Tickers
BMY
From Benzinga
Biohaven Further Deepens Its Neurology Pipeline With Bristol Myers, Knopp Biosciences Deals
February 25, 2022
From Benzinga
This Biotech Company Reports Making Ground-Breaking Strides In Combating Solid Tumors
February 23, 2022
From Benzinga
7 New ETFs To Consider if You Want To Play Today’s Top Trends
February 22, 2022
From InvestorPlace
Golden Cross Appears Before Bristol-Myers Squibb Investors
February 21, 2022
Tickers
BMY
From Benzinga
Will Investors Notice Exciting Sign On Bristol-Myers Squibb's Chart?
February 18, 2022
Tickers
BMY
From Benzinga
The Daily Biotech Pulse: Regeneron-Sanofi Halt Late-Stage Dupixent Study, Agios Gets FDA Nod, Safety Scare For GSK's RSV Vaccine, Shockwave Jumps On Earnings
February 18, 2022
From Benzinga
Bristol Myers Shares Interim Data From Long-Term Study Of Zeposia In Ulcerative Colitis
February 17, 2022
Tickers
BMY
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
February 17, 2022
From Benzinga
The Daily Biotech Pulse: J&J Unit Announces Research Collaboration With Remix, Regencell Touts COVID Data, Decision Day For Agios
February 17, 2022
From Benzinga
3 Desirable Drug Stocks With Very Promising Pipelines
February 16, 2022
From InvestorPlace
Inside Gilead's Lackluster $7.2 Billion Q4 Earnings
February 16, 2022
From Motley Fool
Bristol Myers, Exelixis Tout Additional Opdivo/Cabometyx Combo Data From Kidney Cancer Trial
February 15, 2022
From Benzinga
3 Top Biotech Stocks to Buy Right Now
February 15, 2022
From Motley Fool
Got $1,000? 5 Buffett Stocks to Buy and Hold Forever
February 14, 2022
From Motley Fool
6 Companies That Recently Announced Large Buybacks
February 10, 2022
From Benzinga
The Daily Biotech Pulse: Bristol-Myers Squibb Announces $5B Accelerated Buyback, Qiagen Reaps COVID Testing Windfall, WORLDSymposium Presentations Kick In
February 09, 2022
From Benzinga
2 Natural-Killer Cell Therapy Oncology Companies Investors Should Watch
February 08, 2022
From Benzinga
2 Healthcare Stocks That Could Help Make You a Fortune
February 08, 2022
From Motley Fool
3 Warren Buffett Stocks to Buy Hand Over Fist in February
February 07, 2022
From Motley Fool
Bristol-Myers Squibb (BMY) Q4 2021 Earnings Call Transcript
February 04, 2022
Tickers
BMY
From Motley Fool
5 Biotech Stocks to Buy to Benefit From Biden’s New Cancer Cabinet
February 04, 2022
From InvestorPlace
Bristol Myers Q4 Revenue, FY22 Sales Outlook Lag Consensus
February 04, 2022
Tickers
BMY
From Benzinga
The Daily Biotech Pulse: Sanofi, Bristol-Myers Squibb Gain On Earnings, Valneva-Pfizer Tout Positive Lyme Disease Vaccine Data, UNITY Biotech Restructures
February 04, 2022
From Benzinga
5 Stocks To Watch For February 4, 2022
February 04, 2022
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.